FastImpute: Development and Validation of a Workflow for Open-source, Reference-Free Genotype Imputation Methods - An Example in Breast Cancer (PRS313_BC)

Introduction Genotype imputation improves the resolution of genetic data, but traditional methods are computationally intensive or compromise privacy. Deep learning alternatives are often too large for client-side deployment. In this study, FastImpute, a workflow for creating lightweight, reference-free imputation models, was developed that enables real-time, accessible genetic risk assessment on edge devices. Methods Using whole-genome sequencing data from 2,504 individuals in the 1000 Genomes Project, linear and logistic regression models were trained to impute single-nucleotide polymorphisms (SNPs) used in the breast cancer polygenic risk score PRS313_BC. Models used SNPs from commercial genotyping arrays, and performance was evaluated against sequencing data and benchmarked against Beagle. Results The polygenic risk score (PRS) calculated with our linear model correlated strongly with the PRS from true sequencing data (R² = 0.86), significantly outperforming no imputation and minor allele frequency imputation (R² = 0.38). Our logistic model correctly identified 4 of 6 individuals in the top 1% of breast cancer risk, matching Beagle’s performance. Discussion Our approach balances performance and efficiency, enabling deployment on personal devices and preserving user privacy through local data processing. This approach democratizes access to genetic risk assessment using direct-to-consumer data. However, this proof of concept requires validation across other genomic contexts before clinical use. Conclusion The FastImpute pipeline demonstrates that lightweight models can enable real-time genetic risk assessment on edge devices.

Authors

Institutions

Publication Details

Journal
The Open Bioinformatics Journal
Published
2025-11-28
DOI
https://doi.org/10.2174/0118750362421210250929110508
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FastImpute: Development and Validation of a Workflow for Open-source, Reference-Free Genotype Imputation Methods - An Example in Breast Cancer (PRS313_BC)

Jonas S. Almeida, Jeya Balaji Balasubramanian, Xueyao Wu, Peter Kraft et al.
The Open Bioinformatics Journal
BRCA gene mutations in cancer
article

FastImpute: Development and Validation of a Workflow for Open-source, Reference-Free Genotype Imputation Methods - An Example in Breast Cancer (PRS313_BC)

Jonas S. Almeida, Jeya Balaji Balasubramanian, Xueyao Wu, Peter Kraft, Aaron Ge
article en

Abstract

Introduction Genotype imputation improves the resolution of genetic data, but traditional methods are computationally intensive or compromise privacy. Deep learning alternatives are often too large for client-side deployment. In this study, FastImpute, a workflow for creating lightweight, reference-free imputation models, was developed that enables real-time, accessible genetic risk assessment on edge devices. Methods Using whole-genome sequencing data from 2,504 individuals in the 1000 Genomes Project, linear and logistic regression models were trained to impute single-nucleotide polymorphisms (SNPs) used in the breast cancer polygenic risk score PRS313_BC. Models used SNPs from commercial genotyping arrays, and performance was evaluated against sequencing data and benchmarked against Beagle. Results The polygenic risk score (PRS) calculated with our linear model correlated strongly with the PRS from true sequencing data (R² = 0.86), significantly outperforming no imputation and minor allele frequency imputation (R² = 0.38). Our logistic model correctly identified 4 of 6 individuals in the top 1% of breast cancer risk, matching Beagle’s performance. Discussion Our approach balances performance and efficiency, enabling deployment on personal devices and preserving user privacy through local data processing. This approach democratizes access to genetic risk assessment using direct-to-consumer data. However, this proof of concept requires validation across other genomic contexts before clinical use. Conclusion The FastImpute pipeline demonstrates that lightweight models can enable real-time genetic risk assessment on edge devices.

The Open Bioinformatics JournalVol. 19(1)
University of Maryland, Baltimore (US), National Institutes of Health (US), National Cancer Institute (US), Department of Health and Human Services (US)
National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Openalex Percentile: Top 61%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.